Published in Bull World Health Organ on January 01, 1971
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) (1972) 7.42
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun (1979) 1.51
Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect Immun (1980) 1.19
A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination. J Hyg (Lond) (1976) 1.02
The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2). Postgrad Med J (1976) 0.85
Clinical trial with "R-75" strain live, attenuated, serum inhibitor-resistant intranasal influenza B vaccine. J Clin Microbiol (1977) 0.75
Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature (1967) 3.41
Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol (1969) 3.17
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Attenuation of human influenza A viruses. Br Med J (1969) 1.90
Isolation of temperature-sensitive mutants and the construction of a preliminary genetic map for influenza virus. J Gen Virol (1970) 1.52
Plaque formation of influenza virus at 25 degrees C. Nature (1968) 1.44
Virulence of temperature-sensitive mutants of influenza virus. Br Med J (1969) 1.34
[Study on genetic characteristics of vaccinal strains of influenza viruses type A2]. Vopr Virusol (1962) 1.18
Laboratory characteristics of attenuated influenza viruses. Bull World Health Organ (1969) 1.13
The efficacy of live influenza vaccines. Bull World Health Organ (1969) 0.95
Mutants of influenza virus. Br Med J (1969) 0.93
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) (1972) 7.42
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
Work of a district ethical committee. Br Med J (1979) 3.64
Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature (1967) 3.41
Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol (1969) 3.17
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
A single radial haemolysis technique for the measurement of influenza antibody. J Gen Virol (1975) 2.62
Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology (1988) 2.62
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol (1988) 2.35
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Improvements in a method of growing respiratory viruses in organ cultures. Br J Exp Pathol (1967) 2.13
Some improved techniques for the study of rhinoviruses using HeLa cells. Arch Gesamte Virusforsch (1968) 2.13
Coronaviridae: second report. Intervirology (1978) 2.05
The growth of some myxoviruses in organ cultures. Br J Exp Pathol (1965) 2.05
Cultivation of viruses from a high proportion of patients with colds. Lancet (1966) 2.04
Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines. J Hyg (Lond) (1969) 2.02
Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol (1993) 1.99
Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test. J Clin Microbiol (1981) 1.98
Effects of a "new" human respiratory virus in volunteers. Br Med J (1967) 1.98
Trial of ascorbic acid in prevention of colds. Br Med J (1967) 1.90
Attenuation of human influenza A viruses. Br Med J (1969) 1.90
Recombinant influenza-A viruses as live vaccines for man. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1971) 1.88
A year's experience of the rotavirus syndrome and its association with respiratory illness. Arch Dis Child (1979) 1.85
Resolution of a common RNA sequencing ambiguity by terminal deoxynucleotidyl transferase. Anal Biochem (1986) 1.85
Experiments on the spread of colds. II. Studies in volunteers with coxsackievirus A21. J Hyg (Lond) (1965) 1.82
Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain. Arch Virol (1977) 1.81
An investigation of media for the long term storage of three respiratory viruses. Arch Gesamte Virusforsch (1974) 1.78
Studies on the antiviral activity of amantadine hydrochloride. Ann N Y Acad Sci (1965) 1.74
Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet (1975) 1.74
Toxicity of interferon. Br Med J (Clin Res Ed) (1981) 1.69
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Lancet (1982) 1.66
Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines. J Hyg (Lond) (1977) 1.62
Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis (1982) 1.61
Cytokines and the acute phase response to influenza virus in mice. Am J Physiol (1995) 1.59
Further trials of live influenza vaccine. Br Med J (1966) 1.58
The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol (1967) 1.58
Cultivation of "difficult" viruses from patients with common colds. Br Med J (1968) 1.57
Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis (1984) 1.57
Electron microscopic observations on the entry of influenza virus into susceptible cells. J Gen Virol (1974) 1.55
Coronaviridae. Intervirology (1975) 1.55
Growth of viruses in organ cultures of intestine. Br J Exp Pathol (1970) 1.54
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun (1979) 1.51
Measurement of antibody to influenza virus neuraminidase by single radial hemolysis in agarose gels. Infect Immun (1976) 1.50
Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine (1985) 1.49
A mathematical model of common-cold epidemics on Tristan da Cunha. J Hyg (Lond) (1971) 1.47
Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45
Plaque formation of influenza virus at 25 degrees C. Nature (1968) 1.44
Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. J Infect Dis (1988) 1.43
Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health (1993) 1.43
Virulence for man of a human influenza-A virus antigenically similar to "classical" swine viruses. Lancet (1976) 1.43
A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype. Virus Res (1990) 1.42
Sendai virus infection of rats as a convenient model of acute respiratory infection. Vet Rec (1970) 1.42
Analysis of an influenza A virus mutant with a deletion in the NS segment. J Virol (1984) 1.42
Laboratory and clinical characteristics of attenuated strains of influenza virus. Bull World Health Organ (1969) 1.40
The radiation dosimetry of 99Tcm-exametazime. Nucl Med Commun (1990) 1.39
Live influenza vaccines. Lancet (1983) 1.39
IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. J Immunol (2001) 1.39
Prophylaxis of influenza with a synthetic isoquinoline. Lancet (1968) 1.38
Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers. J Infect Dis (1984) 1.37
Picornaviridae. Intervirology (1974) 1.36
Characterization of an influenza A host range mutant. Virology (1983) 1.36
Failure of oral 4',6-dichloroflavan to protect against rhinovirus infection in man. Arch Virol (1983) 1.35
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
Influenza neuraminidase antibody patterns of man. Am J Epidemiol (1973) 1.32
Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis (1982) 1.31
Antigenic characteristics of swine influenza virus closely related to human Hong Kong strain and results of experimental infection in volunteers. Lancet (1971) 1.31